Delivery Mode Affects Stability of Early Infant Gut Microbiota.
infant gut microbiota, caesarean delivery, Bacteroides, delivery mode, transmission of maternal strains
Journal
Cell reports. Medicine
ISSN: 2666-3791
Titre abrégé: Cell Rep Med
Pays: United States
ID NLM: 101766894
Informations de publication
Date de publication:
22 12 2020
22 12 2020
Historique:
received:
29
01
2020
revised:
29
09
2020
accepted:
19
11
2020
entrez:
30
12
2020
pubmed:
31
12
2020
medline:
31
12
2020
Statut:
epublish
Résumé
Mode of delivery strongly influences the early infant gut microbiome. Children born by cesarean section (C-section) lack
Identifiants
pubmed: 33377127
doi: 10.1016/j.xcrm.2020.100156
pii: S2666-3791(20)30203-2
pmc: PMC7762768
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
100156Subventions
Organisme : NIDDK NIH HHS
ID : K99 DK113224
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK043351
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK092405
Pays : United States
Organisme : NHGRI NIH HHS
ID : U54 HG003067
Pays : United States
Informations de copyright
© 2020 The Author(s).
Déclaration de conflit d'intérêts
C.M.M. receives grant funding from Merck and has served as a consultant for Scynexis. C.H. is a member of the Seres Therapeutics, Empress Therapeutics, and ZOE Nutrition scientific advisory boards. E.S.L. serves on the board of directors for Codiak BioSciences and on the scientific advisory board of F-Prime Capital Partners and Third Rock Ventures; he is also affiliated with several non-profit organizations, including serving on the board of directors of the Innocence Project, Count Me In, and the Biden Cancer Initiative, and the board of trustees for the Parker Institute for Cancer Immunotherapy. He has served and continues to serve on various federal advisory committees. R.J.X. is a consultant to Nestlé.
Références
Nat Med. 2016 Mar;22(3):250-3
pubmed: 26828196
Sci Rep. 2018 Feb 19;8(1):3255
pubmed: 29459704
Front Med (Lausanne). 2018 May 04;5:135
pubmed: 29780807
mSystems. 2018 Nov 13;3(6):
pubmed: 30443602
Nat Commun. 2019 Nov 1;10(1):4997
pubmed: 31676793
Proc Natl Acad Sci U S A. 2010 Jun 29;107(26):11971-5
pubmed: 20566857
Nature. 2018 Oct;562(7728):583-588
pubmed: 30356187
Front Microbiol. 2019 Jun 12;10:1277
pubmed: 31244801
Nat Commun. 2018 Jan 10;9(1):141
pubmed: 29321519
Cell Host Microbe. 2018 Jul 11;24(1):133-145.e5
pubmed: 30001516
Nature. 2019 Oct;574(7776):117-121
pubmed: 31534227
Genome Res. 2016 Nov;26(11):1612-1625
pubmed: 27803195
FEMS Microbiol Ecol. 2008 Dec;66(3):637-44
pubmed: 18785881
mSystems. 2019 Feb 19;4(1):
pubmed: 30801029
Gut. 2014 Apr;63(4):559-66
pubmed: 23926244
Cell Host Microbe. 2015 May 13;17(5):690-703
pubmed: 25974306
Cell Host Microbe. 2018 Jul 11;24(1):146-154.e4
pubmed: 30001517
Microbiome. 2017 Jan 17;5(1):4
pubmed: 28095889
Genome Res. 2018 Apr;28(4):561-568
pubmed: 29496731
Nature. 2012 May 09;486(7402):222-7
pubmed: 22699611
Sci Rep. 2016 Apr 01;6:23133
pubmed: 27033998
mBio. 2015 Feb 03;6(1):
pubmed: 25650398
ISME J. 2012 Mar;6(3):610-8
pubmed: 22134646
Microbiome. 2018 Dec 17;6(1):226
pubmed: 30558668
BJOG. 2016 May;123(6):983-93
pubmed: 26412384
Sci Transl Med. 2016 Jun 15;8(343):343ra82
pubmed: 27306664
PLoS One. 2013 May 03;8(5):e62563
pubmed: 23658745
PLoS One. 2016 Apr 25;11(4):e0152751
pubmed: 27111847
JAMA Pediatr. 2018 Jul 2;172(7):e181161
pubmed: 29868719
J Allergy Clin Immunol. 2017 Feb;139(2):482-491.e14
pubmed: 27746239
JAMA Pediatr. 2016 Mar;170(3):212-9
pubmed: 26752321
Nat Methods. 2015 Oct;12(10):902-3
pubmed: 26418763
J Pediatr Gastroenterol Nutr. 2016 Sep;63(3):320-8
pubmed: 27035381
Nat Med. 2017 Mar;23(3):314-326
pubmed: 28112736
Sci Transl Med. 2016 Jun 15;8(343):343ra81
pubmed: 27306663
Genome Biol. 2012 Apr 16;13(9):R79
pubmed: 23013615
Appl Environ Microbiol. 2013 Feb;79(4):1265-76
pubmed: 23241973
Nat Methods. 2010 May;7(5):335-6
pubmed: 20383131